NCT04690231 2022-03-15Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory OsteosarcomaPeking University People's HospitalPhase NA Completed79 enrolled
NCT00004132 2013-06-26Growth Factor to Prevent Oral Mucositis in Patients With Hematologic CancerNational Cancer Institute (NCI)Phase 2 Completed